IT1141027B - THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES - Google Patents

THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES

Info

Publication number
IT1141027B
IT1141027B IT24347/80A IT2434780A IT1141027B IT 1141027 B IT1141027 B IT 1141027B IT 24347/80 A IT24347/80 A IT 24347/80A IT 2434780 A IT2434780 A IT 2434780A IT 1141027 B IT1141027 B IT 1141027B
Authority
IT
Italy
Prior art keywords
arilchinazolin
ones
treatment
application
autoimmune diseases
Prior art date
Application number
IT24347/80A
Other languages
Italian (it)
Other versions
IT8024347A0 (en
Inventor
Bo Viktor Skrifvars
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of IT8024347A0 publication Critical patent/IT8024347A0/en
Application granted granted Critical
Publication of IT1141027B publication Critical patent/IT1141027B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IT24347/80A 1979-08-30 1980-08-28 THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES IT1141027B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH787179 1979-08-30

Publications (2)

Publication Number Publication Date
IT8024347A0 IT8024347A0 (en) 1980-08-28
IT1141027B true IT1141027B (en) 1986-10-01

Family

ID=4331669

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24347/80A IT1141027B (en) 1979-08-30 1980-08-28 THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES

Country Status (5)

Country Link
JP (1) JPS5636418A (en)
AU (1) AU545003B2 (en)
BE (1) BE884935A (en)
IT (1) IT1141027B (en)
PH (1) PH16864A (en)

Also Published As

Publication number Publication date
BE884935A (en) 1981-02-27
PH16864A (en) 1984-03-22
JPS5636418A (en) 1981-04-09
AU6183680A (en) 1981-03-19
AU545003B2 (en) 1985-06-27
IT8024347A0 (en) 1980-08-28

Similar Documents

Publication Publication Date Title
AP9000206A0 (en) Treatment of conditions & diseases
DK95091D0 (en) USE OF ACETYL-D-CARNITIN FOR THERAPEUTIC TREATMENT OF GLAUCOMA
NL188078C (en) PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF HEART ARRHYTMIES AND MYOCARDIAL DISORDERS.
AU551900B2 (en) Anthralin compositions for treatment of skin diseases
KR900701323A (en) Ophthalmic preparation for the treatment of new glaucoma
IT8009551A0 (en) E-5-(2-HALOGENOVINIL-)-2'DEOXYCYTIDINES, THEIR METHOD OF PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
BG94738A (en) USE OF IODINE SOLUTION FOR THE TREATMENT OF IODINE DEFICIENCY DISEASES
IT8348294A0 (en) COMPOUNDS AND COMPOSITIONS FOR THE TREATMENT OF CARDIOCULATORY DISEASES AND PREPARATION PROCEDURE
FR2573651B1 (en) FORMULA FOR THE REGENERATION OF HUMAN OR ANIMAL DERMIS
ZA79964B (en) 2,6-dialkoxybenzamides,intermediates,pharmaceutical compositions and methods for treatment of psychotic disorders
US4931457B1 (en) Naphthylamino-and naphthyloxy-pyridineamin compounds useful as topical antiinflammatory agents for the treatment of skin disorders
FR2616831B1 (en) ALVEOLAR-TYPE STRUCTURE FOR THE BURIAL OF HUMAN REMAINS
IT9020968A0 (en) METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF OPHTHALMIC DISEASES
IT1271567B (en) PROCEDURE FOR THE FURTHER TREATMENT OF SALCICCE
LV10574A (en) The use of trinitrobenzenes or carmines for the treatment or treatment of diseases
FR2558372B1 (en) DRUG COMPOSITION FOR THE TREATMENT OF ACNE
IT8947740A0 (en) USE OF PROGESTIN FOR THE TREATMENT OF OSTEOPOROSIS
IT7950378A0 (en) THERAPEUTIC MIND HETEROCYCLIC COMPOUNDS VALUABLE IN THE TREATMENT OF AUTOIMMUNE DISEASES
IT1141027B (en) THE APPLICATION OF 4-ARILCHINAZOLIN-2- (1H) -ONES FOR THE TREATMENT OF AUTOIMMUNE DISEASES OF CONNECTIVE TISSUES
IT1098023B (en) PROCEDURE FOR THE ELIMINATION OF NITROSAMINES OF DINITRO-ANILINES
LV10391A (en) The use of alkylphosphorus compounds for the treatment of psoriasis diseases
IT1192563B (en) COMPOSITION FOR THE TREATMENT OF ALLERGIC DISEASES
IT1224741B (en) DEVICE FOR THE TREATMENT OF GENE DISEASES
IT8648617A0 (en) TREATMENT OF INFLAMMATORY JOINT DISEASES
BE883750A (en) PREPARATION OF ISOPROPYLAMINO-2 PYRIMIDINE